Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.

Journal of Clinical Laboratory Analysis
Jiang YuJian-Ping Xu

Abstract

Doxorubicin is a first-line chemotherapy agent on human myelogenous leukemia clinical treatment, but the development of chemoresistance has largely limited curative effect. In this study, we aimed to evaluate the biological function and molecular mechanisms of CrkL to Doxorubicin resistance. Quantitative reverse transcription-PCR (qRT-PCR) assay was performed to examine the expression of CrkL in K562 and K562/ADR cells. The expression of CrkL was silenced through RNA interference technology. MTT assay and flow cytometry were performed to detect the proliferation inhibition and apoptosis rate after CrkL siRNA transfection. The protein expression changes of PI3K/AKT/MRP1 pathway induced by CrkL siRNA were observed by Western Blot assay. Xenograft tumor model was carried out to observe tumor growth in vivo. We observed that silencing of CrkL could effectively increase apoptosis rate induced by doxorubicin and dramatically reversed doxorubicin resistance in K562/ADR cells. Further studies revealed knockdown CrkL expression suppressed PI3K/Akt/MRP1 signaling, which indicated CrkL siRNA reversed doxorubicin effect through regulating PI3K/Akt/MRP1 pathway. In addition, overexpression of MRP1 could evidently reduce apoptosis rate and r...Continue Reading

References

Mar 26, 1999·Journal of Cellular Physiology·S M FellerB S Knudsen
Dec 12, 2012·Genes & Cancer·Emily S Bell, Morag Park
Oct 30, 2013·Immunology and Cell Biology·Dongfang Liu
Nov 12, 2014·Molecular Medicine Reports·Lian Tao LiJun Nian Zheng
Feb 11, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qiuyue LinShuqing Liu
Jun 6, 2015·Cytokine·Gang HanChengjun Li
Oct 17, 2015·Annual Review of Medicine·Ingrid A Mayer, Carlos L Arteaga
Nov 7, 2015·Drug Metabolism Reviews·Jamie F LuMary Bebawy
May 18, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jamie I FletcherMichelle Haber
Jul 21, 2017·Cell Reports·Jing ZhangThomas M Roberts
Jul 21, 2017·Cell Death & Disease·Ilaria GenoveseGianni Colotti
Oct 24, 2017·International Journal of Molecular Sciences·Robert CornelisonCharles N Landen
Nov 16, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kaja FraczkowskaMarta Kopaczynska
May 26, 2018·Clinical & Experimental Metastasis·Michail NikolaouEfthymios Kyrodimos
Oct 7, 2018·Cancer·Hagop M KantarjianEmil J Freireich
Jul 30, 2019·Cancer Biomarkers : Section a of Disease Markers·Runhua FengZhenggang Zhu
Nov 15, 2019·Nature·Neil VasanDavid M Hyman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Bin HanBin Wu
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Chengjun YaoJinsong Wu
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Tingting ZhaoJiguang Li
© 2021 Meta ULC. All rights reserved